Published in PLoS One on November 07, 2007
Resurrection of endogenous retroviruses in antibody-deficient mice. Nature (2012) 1.81
Properties and functions of the nucleocapsid protein in virus assembly. RNA Biol (2010) 1.02
The peculiar interaction between mammalian prion protein and RNA. Prion (2008) 0.86
Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis). Mol Neurodegener (2011) 0.86
LINE-1 retroelements complexed and inhibited by activation induced cytidine deaminase. PLoS One (2012) 0.84
Disease-specific motifs can be identified in circulating nucleic acids from live elk and cattle infected with transmissible spongiform encephalopathies. Nucleic Acids Res (2008) 0.79
Analysis of nucleic acid chaperoning by the prion protein and its inhibition by oligonucleotides. Nucleic Acids Res (2011) 0.78
Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice. PLoS One (2012) 0.76
No reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients. Am J Neurodegener Dis (2014) 0.75
Insertional hypermutation in mineral oil-induced plasmacytomas. Eur J Immunol (2014) 0.75
Cellular Prion Protein Combined with Galectin-3 and -6 Affects the Infectivity Titer of an Endogenous Retrovirus Assayed in Hippocampal Neuronal Cells. PLoS One (2016) 0.75
Infectivity and insertional mutagenesis of endogenous retrovirus in autoimmune NZB and B/W mice. J Gen Virol (2015) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Immunochemistry on ultrathin frozen sections. Histochem J (1980) 8.61
Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus. J Virol (1982) 6.56
Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A (2007) 5.94
RNA molecules stimulate prion protein conversion. Nature (2003) 4.06
The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol (1999) 3.32
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00
A 'unified theory' of prion propagation. Nature (1991) 2.87
Prions and their partners in crime. Nature (2006) 2.55
The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta (2007) 2.09
Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology (1992) 2.00
Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol (1999) 1.90
Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull (2003) 1.89
Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J (2001) 1.85
Production of cattle lacking prion protein. Nat Biotechnol (2006) 1.63
Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J (2006) 1.53
RNA aptamers specifically interact with the prion protein PrP. J Virol (1997) 1.43
Demystified. Human endogenous retroviruses. Mol Pathol (2003) 1.41
The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem (2001) 1.38
Cytosolic prion protein in neurons. J Neurosci (2003) 1.34
Reciprocal interference between specific CJD and scrapie agents in neural cell cultures. Science (2005) 1.34
Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J Immunol (2002) 1.20
Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J Mol Biol (2003) 1.17
Are endogenous C-type viruses involved in the immune system? Nature (1977) 1.07
Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease. J Neurovirol (2004) 1.06
129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment. J Immunol (2002) 1.03
Structural determinants of conformationally selective, prion-binding aptamers. J Biol Chem (2004) 1.00
Scrapie infection activates the replication of ecotropic, xenotropic, and polytropic murine leukemia virus (MuLV) in brains and spinal cords of senescence-accelerated mice: implication of MuLV in progression of scrapie pathogenesis. Biochem Biophys Res Commun (2006) 0.92
Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line. J Mol Biol (2004) 0.90
Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: follicular dendritic cells versus capsule and trabeculae. J Immunol (2003) 0.87
IL-5 and Rp105 signaling defects in B cells from commonly used 129 mouse substrains. J Immunol (1999) 0.87
Prion infection influences murine endogenous retrovirus expression in neuronal cells. Biochem Biophys Res Commun (2006) 0.86
Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. J Med Virol (1996) 0.85
IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell (2011) 3.61
HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc Natl Acad Sci U S A (2008) 3.40
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med (2005) 3.10
Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10
Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol (2006) 3.04
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis (2011) 2.98
Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol (2005) 2.91
Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol (2005) 2.70
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63
Prion strain discrimination using luminescent conjugated polymers. Nat Methods (2007) 2.62
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol (2003) 2.54
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood (2006) 2.53
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell (2012) 2.50
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain (2012) 2.49
Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood (2011) 2.28
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis (2010) 2.21
Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. Cell Host Microbe (2008) 2.15
iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science (2012) 2.14
De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A (2008) 2.10
Chronic lymphocytic inflammation specifies the organ tropism of prions. Science (2005) 2.07
Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med (2003) 2.04
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A (2011) 1.98
Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key. Eur J Immunol (2004) 1.94
Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J Exp Med (2008) 1.94
Coincident scrapie infection and nephritis lead to urinary prion excretion. Science (2005) 1.94
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci U S A (2006) 1.92
Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat Immunol (2004) 1.90
Estimating the basic reproductive number from viral sequence data. Mol Biol Evol (2011) 1.86
The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci (2010) 1.85
Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. Clin Infect Dis (2011) 1.84
Shaken baby syndrome: a common variant of non-accidental head injury in infants. Dtsch Arztebl Int (2009) 1.83
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS (2007) 1.81
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med (2007) 1.80
Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog (2011) 1.71
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol (2012) 1.70
Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. Cell Stem Cell (2008) 1.67
Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology (2003) 1.66
Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol (2009) 1.65
Prion infections, blood and transfusions. Nat Clin Pract Neurol (2006) 1.64
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis (2011) 1.64
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog (2010) 1.63
Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature (2003) 1.51
Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev (2005) 1.50
A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat Immunol (2011) 1.48
Inferring epidemic contact structure from phylogenetic trees. PLoS Comput Biol (2012) 1.47
Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration. Science (2009) 1.47
Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J Exp Med (2003) 1.46
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr (2011) 1.44
Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med (2005) 1.43
Effective T-cell recall responses require the taurine transporter Taut. Eur J Immunol (2012) 1.42
Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Eur J Immunol (2006) 1.41
A versatile prion replication assay in organotypic brain slices. Nat Neurosci (2007) 1.41
A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest (2010) 1.41
CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature (2013) 1.41
Strain fidelity of chronic wasting disease upon murine adaptation. J Virol (2006) 1.40
Natural IgE production in the absence of MHC Class II cognate help. Immunity (2006) 1.40
Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest (2004) 1.39
Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood (2012) 1.39
HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS (2010) 1.38
CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses. J Immunol (2005) 1.37
Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc Natl Acad Sci U S A (2009) 1.35
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency. J Exp Med (2010) 1.35
Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci U S A (2002) 1.33
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology (2010) 1.33
Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol (2009) 1.33
Mechanisms of neonatal mucosal antibody protection. J Immunol (2006) 1.32
Science and sensibility: an interview with Professor Rolf M. Zinkernagel, Nobel Prize Winner for Medicine 1996. Interview by Hrishikesh Satish Kulkarni and Ajit H. Goenka. MedGenMed (2007) 1.30
Effects of promyelocytic leukemia protein on virus-host balance. J Virol (2002) 1.28
EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites. Proc Natl Acad Sci U S A (2007) 1.27
B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood (2012) 1.27
Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J (2005) 1.26
Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy. J Infect Dis (2010) 1.26
Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J Immunol (2002) 1.24